Nevirapine alters the cleavage specificity of ribonuclease H of human immunodeficiency virus 1 reverse transcriptase (Q38297932)

1 September 2017

Nevirapine alters the cleavage specificity of ribonuclease H of human immunodeficiency virus 1 reverse transcriptase (English)

1 reference

1 September 2017

1 reference

human immunodeficiency virus 1

1 reference

Palaniappan C

1

1 reference

1 September 2017

Fay PJ

series ordinal

2

1 reference

1 September 2017

Bambara RA

series ordinal

3

1 reference

1 September 2017

language of work or name

English

0 references

publication date

1 March 1995

1 reference

Journal of Biological Chemistry

1 September 2017

1 reference

1 September 2017

270

1 reference

1 September 2017

4861-4869

1 reference

1 September 2017

9

1 reference

An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-[4,5,1-jk] [1,4]benzodiazepin-2 (1H)-one and -thione derivatives

1 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.9.4861

HIV-1-specific RT inhibitors: highly selective inhibitors of human immunodeficiency virus type 1 that are specifically targeted at the viral reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.9.4861

Determinants of the RNase H cleavage specificity of human immunodeficiency virus reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.9.4861

Resistance of human immunodeficiency virus type 1 reverse transcriptase to TIBO derivatives induced by site-directed mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.9.4861

The human immunodeficiency virus: infectivity and mechanisms of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.9.4861

Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.9.4861

Human immunodeficiency virus type 1 reverse transcriptase: spatial and temporal relationship between the polymerase and RNase H activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.9.4861

Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.9.4861

The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.9.4861

Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.9.4861

Steady state kinetics and inhibition of HIV-1 reverse transcriptase by a non-nucleoside dipyridodiazepinone, BI-RG-587, using a heteropolymeric template

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.9.4861

Interactions between drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.9.4861

Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.9.4861

Differential inhibitory effects of some catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and cellular deoxyribonucleic and ribonucleic acid polymerases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.9.4861

Effect of template secondary structure on the inhibition of HIV-1 reverse transcriptase by a pyridinone non-nucleoside inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.9.4861

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.9.4861

Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.9.4861

Chimeric human immunodeficiency virus type 1/type 2 reverse transcriptases display reversed sensitivity to nonnucleoside analog inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.9.4861

Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.9.4861

Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.9.4861

HIV-1 reverse transcriptase inhibition by a dipyridodiazepinone derivative: BI-RG-587

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.9.4861

Interaction of HIV-1 ribonuclease H with polypurine tract containing RNA-DNA hybrids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.9.4861

A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.9.4861

Mechanism of DNA Strand Transfer Reactions Catalyzed by HIV-1 Reverse Transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.9.4861

Fidelity of in vitro DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.9.4861

21 January 2018

Identifiers

DOI

10.1074/JBC.270.9.4861

1 reference

1 September 2017

1 reference